Intratympanic glucocorticosteroid therapy for idiopathic sudden hearing loss: meta-analysis of randomized controlled trials

View/ open
Author
Lai, Dan
Zhao, Fei
Jalal, Nasim
Zheng, Yun
Date
2017-12-01Acceptance date
2017-11-09
Type
Article
Publisher
Lippincott, Williams and Wilkins
ISSN
0025-7974
1536-5964 (ESSN)
Metadata
Show full item recordAbstract
Background and objective: Glucocorticoids are the standard treatment for idiopathic sudden sensorineural hearing loss (ISSNHL), but whether intratympanic or systemic therapy is superior remains controversial. Previous meta-analyses of this question have omitted key clinical trials or included observational studies.
Methods: English-language randomized controlled trials in OVIDSP, PUBMED, EMBASE, CINAHL and the Cochrane Library comparing intratympanic vs. systemic glucocorticoid therapy for ISSNHL were meta-analyzed using RevMan 5.3. The primary outcome of interest was improvement in pure tone average (PTA) threshold. Results: Six trials involving 248 patients receiving intratympanic steroids and 236 receiving systemic steroids were meta-analyzed. PTA thresholds were similar between the two groups at 3 months after therapy initiation (mean difference, 0.24; 95%CI -2.43 to 2.91, P=.86; I2= 54%, P=.07, random-effects model). PTA thresholds were also similar at 6 months (mean difference, 4.69, 95%CI -5.84 to 15.22, P =.38), although the results showed extremely high heterogeneity (I2= 98%). Sensitivity analysis indicated that a single trial containing 250 patients provided the strongest evidence for equivalence between the two types of therapy. Rates of recovery within 3 months (defined as PTA improvement >10 dB) were similar between the two types of therapy(OR 0.92, 95%CI 0.59 to 1.43, P=.70), with no significant heterogeneity in the pooled data (I2=1%, P=.40).
Conclusion: Intratympanic and systemic steroids therapies appear to show similar short-term efficacy for restoring hearing in patients with ISSNHL. Intratympanic therapy may reduce systemic side effects associated with steroid use.
Journal/conference proceeding
Medicine;
Citation
Lai, D., Zhao, F., Jalal, N. and Zheng, Y. (2017) Intratympanic glucocorticosteroid therapy for idiopathic sudden hearing loss: Meta-analysis of randomized controlled trials. Medicine, 96(50), p.e8955.
Description
This article was published in Medicine in December 2017 available open access at http://dx.doi.org/10.1097/MD.0000000000008955
Collections
Related items
Showing items related by title, author, subject and abstract.
-
A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program—AIM-HY INFORM trial
Mukhtar, O.; Cheriyan, J.; Cockcroft, John R.; Collier, D.; Coulson, J.M.; Dasgupta, I.; Faconti, L.; Glover, M.; Heagerty, A.M.; Khong, T.K.; Lip, G.Y.; Mander, A.P.; Marchong, M.N.; Martin, U.; McDonnell, Barry (Elsevier, 2018-05-20)Background Ethnicity, along with a variety of genetic and environmental factors, is thought to influence the efficacy of antihypertensive therapies. Current UK guidelines use a “black versus white” approach; in doing ... -
Validity and Reliability of Surface Electromyography Measurements from a Wearable Athlete Performance System
Lynn, Scott; Watkins, Casey; Wong, Megan; Balfany, Katherine; Feeney, Daniel (University of Uludag, 2018-05-14)The Athos ® wearable system integrates surface electromyography (sEMG ) electrodes into the construction of compression athletic apparel. The Athos system reduces the complexity and increases the portability of collecting ... -
Medical Terminations of Pregnancy: A Viable Source of Tissue for Cell Replacement Therapy for Neurodegenerative Disorders
Torres, Eduardo; Kelly, Claire; Harrison, A. W.; Williams, D.; Weyrauch, U. M.; Lane, E. L.; Kemp, P. J.; Scherf, Caroline; Precious, Sophie; Allen, Nicholas; Penketh, Richard; Amso, Nazar; Dunnett, Stephen; Rosser, Anne (Cognizant Communication Corporation, 2011)"Proof-of-principle" that cell replacement therapy works for neurodegeneration has been reported, but only using donor cells collected from fetal brain tissue obtained from surgical terminations of pregnancy. Surgical ...